blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2749572

EP2749572 - NOVEL ANTI-DDR1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.10.2020
Database last updated on 31.08.2024
FormerGrant of patent is intended
Status updated on  08.12.2019
FormerExamination is in progress
Status updated on  11.11.2016
Most recent event   Tooltip09.10.2020Application deemed to be withdrawnpublished on 11.11.2020  [2020/46]
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome Kita-ku
Tokyo 115-8543 / JP
[2014/27]
Inventor(s)01 / ONO, Mei
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
200 Kajiwara
Kamakura-shi Kanagawa 247-8530 / JP
02 / SANO, Yuji
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
200 Kajiwara
Kamakura-shi Kanagawa 247-8530 / JP
03 / SUZUKI, Tsukasa
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
135 Komakado 1-chome
Gotemba-shi Shizuoka 412-8513 / JP
 [2014/27]
Representative(s)Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2014/27]Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68
81675 München / DE
Application number, filing date12826213.623.08.2012
WO2012JP71332
Priority number, dateJP2011018168323.08.2011         Original published format: JP 2011181683
[2014/27]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013027802
Date:28.02.2013
Language:JA
[2013/09]
Type: A1 Application with search report 
No.:EP2749572
Date:02.07.2014
Language:EN
[2014/27]
Search report(s)International search report - published on:JP28.02.2013
(Supplementary) European search report - dispatched on:EP26.02.2015
ClassificationIPC:C07K16/30, A61K39/395, A61P35/00, C12N1/15, C12N1/19, C12N1/21, C12N5/10, C12N15/09, C12P21/08, C07K16/28, A61K47/18, C07K16/40, A61K39/00
[2018/03]
CPC:
C07K16/2851 (EP,US); C07K16/40 (US); A61K39/3955 (US);
A61P35/00 (EP); C07K16/3023 (EP,US); A61K2039/505 (EP,US);
C07K2317/34 (EP,US); C07K2317/76 (EP,US); C07K2317/77 (EP,US) (-)
Former IPC [2015/14]C07K16/30, A61K39/395, A61P35/00, C12N1/15, C12N1/19, C12N1/21, C12N5/10, C12N15/09, C12P21/08, C07K16/28, A61K47/18, C07K16/40, A61K47/48, A61K39/00
Former IPC [2014/27]C07K16/30, A61K39/395, A61P35/00, C12N1/15, C12N1/19, C12N1/21, C12N5/10, C12N15/09, C12P21/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/27]
TitleGerman:NEUER ANTI-DDR1-ANTIKÖRPER MIT ANTITUMORAKTIVITÄT[2014/27]
English:NOVEL ANTI-DDR1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY[2014/27]
French:NOUVEL ANTICORPS ANTI-DDR1 AYANT UNE ACTIVITÉ ANTI-TUMORALE[2014/27]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase21.03.2014Translation filed 
21.03.2014National basic fee paid 
21.03.2014Search fee paid 
21.03.2014Designation fee(s) paid 
21.03.2014Examination fee paid 
Examination procedure21.03.2014Examination requested  [2014/27]
22.09.2015Amendment by applicant (claims and/or description)
10.11.2016Despatch of a communication from the examining division (Time limit: M04)
06.02.2017Reply to a communication from the examining division
06.07.2017Despatch of a communication from the examining division (Time limit: M04)
25.09.2017Reply to a communication from the examining division
21.03.2018Despatch of a communication from the examining division (Time limit: M04)
26.07.2018Reply to a communication from the examining division
04.10.2018Despatch of a communication from the examining division (Time limit: M04)
14.11.2018Reply to a communication from the examining division
03.04.2019Despatch of a communication from the examining division (Time limit: M02)
17.05.2019Reply to a communication from the examining division
09.12.2019Communication of intention to grant the patent
03.06.2020Application deemed to be withdrawn, date of legal effect  [2020/46]
25.06.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/46]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.11.2016
Fees paidRenewal fee
25.08.2014Renewal fee patent year 03
20.08.2015Renewal fee patent year 04
22.08.2016Renewal fee patent year 05
22.08.2017Renewal fee patent year 06
28.08.2018Renewal fee patent year 07
26.08.2019Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.08.202009   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XDI]WO2010019702  (ONCOMED PHARM INC [US], et al) [XD] 1,4-14,16 * See § 0072, claims 1-66 *[I] 2,3,15
International search[X]JP2005521420  (AGY THERAPEUTICS, INC.);
 [Y]WO2006098465  (TAKEDA PHARMACEUTICAL [JP], et al);
 [Y]WO2010019702  (ONCOMED PHARM INC [US], et al);
 [Y]  - ABDULHUSSEIN R. ET AL., "Identification of Disulfide-linked Dimers of the Receptor Tyrosine Kinase DDR1", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2008), vol. 283, no. 18, pages 12026 - 12033, XP055145958

DOI:   http://dx.doi.org/10.1074/jbc.M704592200
 [Y]  - GUERROT D. ET AL., "Discoidin Domain Receptor 1 Is a Major Mediator of Inflammation and Fibrosis in Obstructive Nephropathy", THE AMERICAN JOURNAL OF PATHOLOGY, (201107), vol. 179, no. 1, pages 83 - 91, XP055145961

DOI:   http://dx.doi.org/10.1016/j.ajpath.2011.03.023
 [XP]  - CARAFOLI F. ET AL., "Structure of the Discoidin Domain Receptor 1 Extracellular Region Bound to an Inhibitory Fab Fragment Reveals Features Important for Signaling", STRUCTURE, (201204), vol. 20, pages 688 - 697, XP055090582

DOI:   http://dx.doi.org/10.1016/j.str.2012.02.011
by applicantEP0239400
 JPH0159878B
 EP0404097
 US5057313
 WO9201047
 WO9203918
 US5156840
 WO9220791
 WO9306213
 WO9311236
 WO9311161
 WO9312227
 WO9319172
 WO9402602
 WO9411523
 WO9425585
 WO9501438
 WO9502187
 WO9515388
 WO9602576
 WO9634096
 WO9633735
 WO2006098465
 WO2010001972
 WO2010019702
    - JOHNSON J.D. ET AL., PROC.NATL.ACAD.SCI.USA, (1993), vol. 90, pages 5677 - 81
    - SHINTANI Y ET AL., J. CELL BIOL., (2008), vol. 180, pages 1277 - 89
    - CURAT C.A. ET AL., J.BIOL.CHEM., (2001), vol. 276, pages 45952 - 58
    - ABDULHUSSEIN R. ET AL., J.BIOL.CHEM., (2008), vol. 283, pages 12026 - 12033
    - FRANCO C. ET AL., CIRC.RES., (2009), vol. 105, pages 1141 - 8
    - SHIMADA K. ET AL., CANCER SCI., (2008), vol. 99, pages 39 - 45
    - KIM H.G. ET AL., J.BIOL.CHEM., (2011), vol. 286, pages 17672 - 81
    - YANG S.H. ET AL., ONCOL.REP, (2010), vol. 24, pages 311 - 9
    - RAM R. ET AL., J.NEUROONCO1., (2006), vol. 76, pages 239 - 48
    - KIMMAN M.L. ET AL., BMC CANCER, (2007), vol. 7, pages 1 - 20
    - COLAS E. ET AL., INT.J.CANCER, (2011), page 129
    - HEINZELMANN-SCHWARZ VA. ET AL., CLIN.CANCER RES., (2004), vol. 10, pages 4427 - 36
    - RIKOVA K. ET AL., CELL, (2007), vol. 131, pages 1190 - 203
    - GU T.L. ET AL., PLOS ONE, (2011), vol. 6, page E15640
    - YAMANAKA R. ET AL., ONCOGENE, (2006), vol. 25, pages 5994 - 6002
    - HIDALGO-CARCEDO C. ET AL., NAT.CELL BIOL., (2011), vol. 13, pages 49 - 58
    - YANG, S. H. ET AL., ONCOL. REP., (2010), vol. 24, pages 311 - 319
    - VOGEL, W. ET AL., MOL. CELL, (1997), vol. 1, pages 13 - 23
    - L'HOTE, C. G M. ET AL., FASEB J, (2002), vol. 16, pages 234 - 6
    - RIKOVA, K. ET AL., CELL, (2007), vol. 131, pages 1190 - 203
    - SHINTANI, Y ET AL., J. CELL. BIOL., (2008), vol. 180, pages 1277 - 1289
    - GUERROT, D. ET AL., AM. J. PATHOL., (2011), vol. 179, pages 83 - 91
    - POETZ, O. ET AL., PROTEOMICS, (2005), vol. 5, pages 2402 - 11
    - VYAS, N. K. ET AL., BIOCHEMISTRY, (2004), vol. 41, pages 13575 - 86
    - CUNNINGHAM, B. C.; WELLS, J. A., SCIENCE, (1989), vol. 244, pages 1081 - 5
    - SMITH, G. P.; PETRENKO, V A., CHEM. REV., (1997), vol. 97, pages 391 - 410
    - HASHIMOTO-GOTOH, T. ET AL., GENE, (1995), vol. 152, pages 271 - 275
    - ZOLLER, M. J.; SMITH, M., METHODS ENZYMOL., (1983), vol. 100, pages 468 - 500
    - KRAMER, W. ET AL., NUCLEIC ACIDS RES., (1987), vol. 12, pages 9441 - 9456
    - KRAMER W; FRITZ H. J., METHODS ENZYMOL, (1987), vol. 154, pages 350 - 367
    - KUNKEL, T. A., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 488 - 492
    - MARK, D. F. ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 5662 - 5666
    - WANG, A. ET AL., SCIENCE, (1984), vol. 224, pages 1431 - 1433
    - SAMBROOK J. ET AL., Molecular Cloning, COLD SPRING HARBOR LAB.PRESS, (1989), pages 9.47 - 9.58
    - J.IMMUNOL., (1979), vol. 123, pages 1548 - 1550
    - CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, (1978), vol. 81, pages 1 - 7
    - KOHLER G; MILSTEIN C., EUR.J.IMMUNOL., (1976), vol. 6, pages 511 - 519
    - MARGULIES D.H. ET AL., CELL, (1976), vol. 8, pages 405 - 415
    - SHULMAN M. ET AL., NATURE, (1978), vol. 276, pages 269 - 270
    - DE ST.GROTH S.F. ET AL., J.IMMUNOL.METHODS, (1980), vol. 35, pages 1 - 21
    - TROWBRIDGE I.S.J., EXP.MED., (1978), vol. 148, pages 313 - 323
    - GALFRE G ET AL., NATURE, (1979), vol. 277, pages 131 - 133
    - KOHLER G; MILSTEIN C., METHODS ENZYMOL., (1981), vol. 73, pages 3 - 46
    - VANDAMME, A.M. ET AL., EUR. J. BIOCHEM., (1990), vol. 192, pages 767 - 775
    - CHIRGWIN, J.M. ET AL., BIOCHEMISTRY, (1979), vol. 18, pages 5294 - 5299
    - CHOMCZYNSKI, P. ET AL., ANAL. BIOCHEM., (1987), vol. 162, pages 156 - 159
    - FROHMAN, M.A. ET AL., PROC. NATL ACAD. SCI. U. S. A., (1988), vol. 85, pages 8998 - 9002
    - BELYAVSKY, A. ET AL., NUCLEIC ACIDS RES., (1989), vol. 17, pages 2919 - 2932
    - J. MOL. BIOL., (1991), vol. 222, pages 581 - 597
    - NATURE, (1979), vol. 277, page 108
    - MIZUSHIMA ET AL., NUCLEIC ACIDS RES., (1990), vol. 18, page 5322
    - NATURE, (1989), vol. 341, pages 544 - 546
    - FASEB J, (1992), vol. 6, pages 2422 - 2427
    - BETTER ET AL., SCIENCE, (1988), vol. 240, pages 1041 - 1043
    - LEI, S. P ET AL., J. BACTERIOL., (1987), vol. 169, page 4379
    - EBERT, K. M. ET AL., BIO/TECHNOLOGY, (1994), vol. 12, pages 699 - 702
    - SUSUMU ET AL., NATURE, (1985), vol. 315, pages 592 - 4
    - MA ET AL., EUR. J. IMMUNOL., (1994), vol. 24, pages 131 - 8
    - SATO, K. ET AL., CANCER RES., (1993), vol. 53, pages 851 - 856
    - CO M.S. ET AL., J.IMMUNOL., (1994), vol. 152, pages 2968 - 2976
    - BETTER M.; HORWITZ A.H., METHODS IN ENZYMOLOGY, (1989), vol. 178, pages 476 - 496
    - PLUCKTHUN A.; SKERRA A., METHODS IN ENZYMOLOGY, (1989), vol. 178, pages 497 - 515
    - LAMOYI E., METHODS IN ENZYMOLOGY, (1986), vol. 121, pages 652 - 663
    - ROUSSEAUX J. ET AL., METHODS IN ENZYMOLOGY, (1986), vol. 121, pages 663 - 669
    - BIRD R.E.; WALKER B.W., TRENDS BIOTECHNOL., (1991), vol. 9, pages 132 - 137
    - HUSTON, J. S. ET AL., PROC. NATL ACAD. SCI. U. S. A., (1988), vol. 85, pages 5879 - 5883
    - HOLLIGER, P. ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 6444 - 6448
    - HUDSON, P. J.; KORTT, A. A., J. IMMUNOL. METHODS, (1999), vol. 231, pages 177 - 189
    - PROTEIN ENGINEERING, (1996), vol. 9, pages 299 - 305
    - MOL. CELL. BIOL., (1988), vol. 8, pages 466 - 472
    - Remington's Pharmaceutical Science, MARK PUBLISHING COMPANY
    - PACE C.N. ET AL., PROTEIN SCI., (1995), vol. 4, pages 2411 - 2423
    - LARRICK, J. W. ET AL., BIOCHEM. BIOPHYS. RES. COMMUN, (1989), vol. 160, pages 1250 - 1256
    - JONES, S. T.; BENDIG, M. M., BIOTECHNOLOGY, (1991), vol. 9, page 579
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.